Literature DB >> 29475854

Sialendoscopy enhances salivary gland function in Sjögren's syndrome: a 6-month follow-up, randomised and controlled, single blind study.

K Hakki Karagozoglu1, Arjan Vissink2, Tim Forouzanfar1, Henk S Brand3, Floor Maarse1, Derk Hendrik Jan Jager1,4.   

Abstract

OBJECTIVES: To assess the effect of sialendoscopy of the major salivary glands on salivary flow and xerostomia in patients with Sjögren's syndrome (SS).
METHODS: Forty-nine patients with SS were randomly assigned to a control group (n=15) and two intervention groups: irrigation of the major glands with saline (n=16) or with saline followed by triamcinolone acetonide (TA) in saline (n=18). Unstimulated whole saliva flow (UWS), chewing-stimulated whole saliva flow (SWS), citric acid-stimulated parotid flow (SPF), Clinical Oral Dryness Score (CODS), Xerostomia Inventory (XI) score and the European League Against Rheumatism (EULAR) SS Patient-Reported Index (ESSPRI) were obtained 1 week (T0) before, and 1 (T1), 8 (T8), 16 (T16) and 24 (T24) weeks after sialendoscopy.
RESULTS: Median baseline UWS, SWS and SPF scores were 0.14, 0.46 and 0.22 mL/min, respectively. After intervention, significant increases in UWS and SWS were observed in the saline group (at T8 (P=0.013) and T24 (P=0.004)) and the saline/TA group (at T24 (P=0.03) and T=16 (P=0.035)). SPF was increased significantly in the saline/TA group at T24 (P=0.03). XI scores declined after sialendoscopy in both intervention groups. Compared with the control group, CODS, XI and ESSPRI improved in the intervention groups. UWS, SWS and SPF were higher in the intervention groups compared with the control group, but these differences were not significant except for SPF in the saline/TA group at T24 (P=0.005).
CONCLUSIONS: Irrigation of the major salivary glands in patients with SS enhances salivary flow and reduces xerostomia up to 6 months after sialendoscopy. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Sjøgren’s syndrome; corticosteroids; treatment

Mesh:

Substances:

Year:  2018        PMID: 29475854     DOI: 10.1136/annrheumdis-2017-212672

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

Review 1.  Sjögren syndrome: looking forward to the future.

Authors:  Sara Zandonella Callegher; Ivan Giovannini; Sabine Zenz; Valeria Manfrè; Martin H Stradner; Alojzija Hocevar; Marwin Gutierrez; Luca Quartuccio; Salvatore De Vita; Alen Zabotti
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-23       Impact factor: 3.625

2.  Correlation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests.

Authors:  Ola Hijjaw; Mohammad Alawneh; Khaled Ojjoh; Hazem Abuasbeh; Ahmad Alkilany; Nabeel Qasem; Mohammad Al-Essa; Saif Aldeen AlRyalat
Journal:  Open Access Rheumatol       Date:  2019-01-04

3.  Sialendoscopy increases saliva secretion and reduces xerostomia up to 60 weeks in Sjögren's syndrome patients: a randomized controlled study.

Authors:  K Hakki Karagozoglu; Arjan Vissink; Tim Forouzanfar; Jan G A M de Visscher; Floor Maarse; Henk S Brand; Peter M van de Ven; Derk H Jan Jager
Journal:  Rheumatology (Oxford)       Date:  2021-03-02       Impact factor: 7.580

4.  P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren's syndrome mouse model.

Authors:  Kimberly J Jasmer; Lucas T Woods; Kevin Muñoz Forti; Adam L Martin; Jean M Camden; Marco Colonna; Gary A Weisman
Journal:  Arch Oral Biol       Date:  2021-02-03       Impact factor: 2.633

5.  Preliminary study on the efficacy of xerostomia treatment with sialocentesis targeting thyroid disease patients given radioiodine therapy.

Authors:  Euy-Hyun Kim; Dong-Keon Lee; Chang-Woo Kim; In-Seok Song; Sang-Ho Jun
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.